SCHEMBL20109153

SCHEMBL20109153

C=C(CC)P1(=O)N(c2ccc(C)cc2)CCN1c1ccc(C)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
HTT P42858 3/20 0.33
ELANE P08246 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
RAB9A P51151 2/20 0.33
PKM P14618 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
MITF O75030 1/20 0.33
TP53 P04637 1/20 0.33
AKR1C3 P42330 1/20 0.33
ALOX5 P09917 1/20 0.33
ADRB1 P08588 1/20 0.33
F2 P00734 1/20 0.32
CTSG P08311 1/20 0.32
CMA1 P23946 1/20 0.32
CTRC Q99895 1/20 0.32
GLA P06280 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109142 0.90 GFER (0.43) KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20109140 0.85 CHRNA7 (0.36) MEN1KMT2AHTTELANERAB9A
SCHEMBL17596721 0.82 MEN1 (0.42) MEN1KMT2ASMN1; SMN2RAB9AKDM4E
SCHEMBL20109231 0.81 ADRB1 (0.33) MEN1KMT2AHTTELANERAB9A
SCHEMBL20109348 0.76 GFER (0.42) MEN1KMT2ARAB9AMAPTALDH1A1
SCHEMBL20109254 0.73 GFER (0.41) MEN1KMT2ASMN1; SMN2MAPTALDH1A1
SCHEMBL20109217 0.73 GFER (0.41) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL17596797 0.71 CASP3 (0.39) MEN1KMT2AHTTSMN1; SMN2MAPT
SCHEMBL20109147 0.70 DPP4 (0.39) MEN1KMT2ASMN1; SMN2
SCHEMBL20113439 0.69 MEN1 (0.41) MEN1KMT2ARAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 MEN1 469/4885KMT2A 2508/4885HTT 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.